Overview

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

Status:
Completed
Trial end date:
2002-12-20
Target enrollment:
Participant gender:
Summary
To compare the safety and tolerability of etoricoxib and diclofenac sodium in the treatment of osteoarthritis of the knee or hip during a six week period.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Diclofenac
Etoricoxib